Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Operating Expenses | 4,883 | 6,090 | 1,770 | 6,450 | 7,030 |
| Operating Income | -4,883 | -6,090 | -1,770 | -6,450 | -7,030 |
| Interest Expense | 0 | 0 | 0 | 350 | 1,850 |
| Other Income | -746 | -1,370 | 0 | -2,630 | 5,690 |
| Pre-tax Income | -5,629 | -7,460 | -1,770 | -9,430 | -3,190 |
| Net Income Continuous | -5,629 | -8,836 | -5,500 | -9,400 | -3,193 |
| Net Income | $-5,629 | $-7,460 | $-5,500 | $-9,430 | $-3,190 |
| EPS Basic Total Ops | -0.93 | -1.20 | -0.42 | -1.44 | -0.66 |
| EPS Basic Continuous Ops | -0.60 | -1.10 | -0.68 | -1.44 | -0.66 |
| EPS Diluted Total Ops | -0.93 | -1.20 | -0.42 | -1.44 | -0.66 |
| EPS Diluted Continuous Ops | -0.60 | -1.10 | -0.68 | -1.44 | -0.66 |
| EBITDA(a) | $-4,871 | $-6,060 | $-1,730 | $-6,390 | $-6,970 |